Oxilight logo

Oxilight

4 employees · est. 2015 · Toronto, Canada

VS
Syros Pharmaceuticals logo

Syros Pharmaceuticals

By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients

88 employees · est. 2012 · Cambridge, United States

Syros Pharmaceuticals is the older company (2015 vs 2012); Syros Pharmaceuticals is the larger of the two.

Side-by-Side Comparison

Oxilight Syros Pharmaceuticals
Founded
2015 2012 older
Headquarters
Toronto, Canada Cambridge, United States
Employees
4 88 larger
Industry
Biotechnology, Health Care, Medical Devices Biotechnology, Life Sciences, Pharmaceutical
Funding Stage
Seed IPO
Total Funding
Not tracked yet $494.90M
Funding Rounds
2 11
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Gene Expression Control, Hematologic Malignancies, Small Molecule Therapeutics, RARα Agonist, Myelodysplastic Syndrome, RARA Gene Overexpression, Oncology, Gene Regulatory Circuits, Drug Discovery, Bioinformatics, Assay Technologies, Genomic Data Integration, Biologic Insights
Website
oxilight.ca syros.com
Oxilight logo

About Oxilight

Oxilight Inc is a biomedical device company that specializes in developing advanced imaging technologies for wound care. The company, founded in 2015, aims to make wound imaging technologies accessible to frontline healthcare professionals. Its vision is to empower frontline healthcare providers to...

Syros Pharmaceuticals logo

About Syros Pharmaceuticals

Syros Pharmaceuticals, founded in 2012, is a trailblazer in the Biotechnology and Pharmaceutical industries, known for its mission: "By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients". Headquartered in the United States, Syros is...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Oxilight and Syros Pharmaceuticals — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Oxilight and Syros Pharmaceuticals — by email.

Frequently Asked Questions

Oxilight. Syros Pharmaceuticals — By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Oxilight has raised undisclosed funding while Syros Pharmaceuticals has raised $494.90M.
Oxilight and Syros Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Oxilight with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy